The structural biology of type I viral membrane fusion

[1]  D. Chan,et al.  The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide Regions* , 2003, The Journal of Biological Chemistry.

[2]  L. McGinnes,et al.  Evidence for Mixed Membrane Topology of the Newcastle Disease Virus Fusion Protein , 2003, Journal of Virology.

[3]  R. Compans,et al.  Mutations in the Cytoplasmic Domain of a Paramyxovirus Fusion Glycoprotein Rescue Syncytium Formation and Eliminate the Hemagglutinin-Neuraminidase Protein Requirement for Membrane Fusion , 2003, Journal of Virology.

[4]  S. Crennell,et al.  Role of the Hemagglutinin-Neuraminidase Protein in the Mechanism of Paramyxovirus-Cell Membrane Fusion , 2002, Journal of Virology.

[5]  Peter D. Kwong,et al.  HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.

[6]  W. Newcomb,et al.  New Insights into the Spring-Loaded Conformational Change of Influenza Virus Hemagglutinin , 2002, Journal of Virology.

[7]  Brian J. Smith,et al.  Modelling the structure of the fusion protein from human respiratory syncytial virus. , 2002, Protein engineering.

[8]  A. Debnath,et al.  Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles , 2002, BMC infectious diseases.

[9]  A. Debnath,et al.  Peptide and non-peptide HIV fusion inhibitors. , 2002, Current pharmaceutical design.

[10]  M. Lawrence,et al.  Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus. , 2001, Virology.

[11]  M. Tsurudome,et al.  Hemagglutinin-Neuraminidase-Independent Fusion Activity of Simian Virus 5 Fusion (F) Protein: Difference in Conformation between Fusogenic and Nonfusogenic F Proteins on the Cell Surface , 2001, Journal of Virology.

[12]  R. Lamb,et al.  Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion , 2001, The EMBO journal.

[13]  S. Crennell,et al.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase , 2001, Nature Structural Biology.

[14]  R. Lamb,et al.  Paramyxovirus fusion (F) protein: a conformational change on cleavage activation. , 2001, Virology.

[15]  M. Lawrence,et al.  The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. , 2001, Structure.

[16]  F. Heinz,et al.  Structures and mechanisms in flavivirus fusion , 2000, Advances in Virus Research.

[17]  P S Kim,et al.  Structural characterization of the human respiratory syncytial virus fusion protein core. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Zimmerberg,et al.  The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA , 2000, Journal of Virology.

[19]  G. Melikyan,et al.  Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion , 2000, The Journal of cell biology.

[20]  S. Schreiber,et al.  The structure of an HIV-1 specific cell entry inhibitor in complex with the HIV-1 gp41 trimeric core. , 2000, Bioorganic & medicinal chemistry.

[21]  W A Hendrickson,et al.  Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. McGinnes,et al.  A Single Amino Acid Change in the Newcastle Disease Virus Fusion Protein Alters the Requirement for HN Protein in Fusion , 2000, Journal of Virology.

[23]  J. Skehel,et al.  Temperature dependence of fusion by sendai virus. , 2000, Virology.

[24]  J. Skehel,et al.  Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. , 2000, Virology.

[25]  R. Lamb,et al.  Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. , 2000, Virology.

[26]  Y. Ito,et al.  An amino acid in the heptad repeat 1 domain is important for the haemagglutinin-neuraminidase-independent fusing activity of simian virus 5 fusion protein. , 2000, The Journal of general virology.

[27]  J. Sodroski,et al.  Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.

[28]  J. Bentz.  Membrane fusion mediated by coiled coils: a hypothesis. , 2000, Biophysical journal.

[29]  J. Binley,et al.  A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure , 2000, Journal of Virology.

[30]  P. S. Kim,et al.  Inhibiting HIV-1 Entry Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket , 1999, Cell.

[31]  A. Debnath,et al.  Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1. , 1999, Journal of medicinal chemistry.

[32]  J. Skehel,et al.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Morrison,et al.  Interaction of Peptides with Sequences from the Newcastle Disease Virus Fusion Protein Heptad Repeat Regions , 1999, Journal of Virology.

[34]  P. Wingfield,et al.  The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. , 1999, Journal of structural biology.

[35]  T. Morrison,et al.  Mutational Analysis of Heptad Repeats in the Membrane-Proximal Region of Newcastle Disease Virus HN Protein , 1999, Journal of Virology.

[36]  R. Doms,et al.  Functional Dissection of CCR5 Coreceptor Function through the Use of CD4-Independent Simian Immunodeficiency Virus Strains , 1999, Journal of Virology.

[37]  R. Lamb,et al.  Structural basis for paramyxovirus-mediated membrane fusion. , 1999, Molecular cell.

[38]  M. Marinello,et al.  Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. , 1999, Virology.

[39]  P S Kim,et al.  Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Eric Hunter,et al.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.

[41]  David J Stevens,et al.  Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation , 1998, Cell.

[42]  M. Kozlov,et al.  A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. , 1998, Biophysical journal.

[43]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[44]  B. O'hara,et al.  CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats. , 1998, Antiviral research.

[45]  C. Weiss,et al.  Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.

[46]  T. Matthews,et al.  Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides , 1998, Journal of Virology.

[47]  Y. Ito,et al.  Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation , 1997, Journal of virology.

[48]  T. Morrison,et al.  Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells , 1997, Journal of virology.

[49]  W. Weissenhorn,et al.  Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[51]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[52]  P. Earl,et al.  Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein , 1997, Journal of virology.

[53]  R. Compans,et al.  Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces , 1997, Journal of virology.

[54]  R. Compans,et al.  Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion , 1996, Journal of virology.

[55]  R. Compans,et al.  Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. , 1996, Virology.

[56]  T. Vorherr,et al.  H+-induced Membrane Insertion of Influenza Virus Hemagglutinin Involves the HA2 Amino-terminal Fusion Peptide but Not the Coiled Coil Region* , 1996, The Journal of Biological Chemistry.

[57]  D. Lambert,et al.  Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Q. Sattentau,et al.  Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation , 1996, The Journal of experimental medicine.

[59]  R. Bethell,et al.  Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en , 1996, Antimicrobial agents and chemotherapy.

[60]  P. Colman,et al.  Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en. , 1995, Virology.

[61]  Y. Shai,et al.  A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus‐cell fusion: an emerging similarity with functional domains of other viruses. , 1995, The EMBO journal.

[62]  R. Lamb,et al.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus , 1995, Journal of virology.

[63]  T. Takimoto,et al.  A single amino acid changes enhances the fusion promotion activity of human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. , 1995, Virology.

[64]  T. Takimoto,et al.  Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. , 1994, Virology.

[65]  T. Matthews,et al.  Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[66]  P. Colman.  Influenza virus neuraminidase: Structure, antibodies, and inhibitors , 1994, Protein science : a publication of the Protein Society.

[67]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[68]  P. Earl,et al.  Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities , 1994, Journal of virology.

[69]  Q. Sattentau,et al.  Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding , 1993, Journal of virology.

[70]  Mark K. Bennett,et al.  A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.

[71]  R. Lamb.  Paramyxovirus fusion: a hypothesis for changes. , 1993, Virology.

[72]  J. Sodroski,et al.  Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.

[73]  J. Bentz.  Viral Fusion Mechanisms , 1993 .

[74]  T. Oas,et al.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Sodroski,et al.  Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events , 1992, Journal of virology.

[76]  R. Ray,et al.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses , 1992, Journal of virology.

[77]  J. Skehel,et al.  Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity , 1992, Cell.

[78]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[79]  Q. Sattentau,et al.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.

[80]  K. Dimock,et al.  The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. , 1991, Virology.

[81]  R Buckland,et al.  Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. , 1991, The Journal of general virology.

[82]  C. Pringle,et al.  Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. , 1990, The Journal of general virology.

[83]  Q. Sattentau,et al.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.

[84]  F. Gaeta,et al.  ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. , 1990, Science.

[85]  F. Wild,et al.  Leucine zipper motif extends , 1989, Nature.

[86]  J. Skehel,et al.  Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. , 1986, Virology.

[87]  J. Skehel,et al.  Studies of influenza haemagglutinin-mediated membrane fusion. , 1986, Virology.

[88]  I. Wilson,et al.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[89]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[90]  C. Ward,et al.  Influenza virus haemagglutinin. Structural predictions suggest that the fibrillar appearance is due to the presence of a coiled-coil. , 1980, Australian journal of biological sciences.

[91]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[92]  J. Sodroski,et al.  Energetics of the HIV gp 120-CD 4 binding reaction , 2000 .

[93]  G. Krishnamurthy,et al.  Inhibition of respiratory syncytial virus by a new class of chemotherapeutic agents , 2000 .

[94]  R. Doms,et al.  HIV-1 Membrane Fusion: Targets of Opportunity , 2000 .

[95]  S. Harrison,et al.  Structural basis for membrane fusion by enveloped viruses. , 1999, Molecular membrane biology.

[96]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[97]  Stephen C. Blacklow,et al.  A trimeric structural domain of the HIV-1 transmembrane glycoprotein , 1995, Nature Structural Biology.